A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/335 (2006.01) A61P 27/02 (2006.01) A61P 43/00 (2006.01) C07D 313/12 (2006.01)
Patent
CA 2306393
Ophthalmic formulations containing as an active ingredient 11-(3- dimethylaminopropylidene) -6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof are useful for inhibiting cytokine release (e.g., IL-6 and IL-8) from human ocular cells. Such formulations can be used to treat or prevent ocular neovascularization and non-allergic inflammatory disorders such as dry-eye, keratitis, blepharitis, uveitis and inflammation related to infection.
Des formulations ophtalmiques contenant en tant que principe actif de l'acide 11-(3-diméthylaminopropylidène) -6,11-dihydrodibenz POUND b,e]oxépin-2-acétique ou un sel pharmaceutique acceptable de celui-ci sont utiles pour empêcher la libération de cytokine (par exemple, IL-6 et IL-8) par les cellules oculaires humaines. Ces formulations peuvent être utilisées pour traiter ou prévenir la néoformation de vaisseaux sanguins oculaires et les troubles inflammatoires non allergiques tels que l'oeil sec, la kératite, la blépharite, l'uvéite et l'inflammation associée à l'infection.
Gamache Daniel A.
Weimer Lori K.
Yanni John M.
Alcon Laboratories Inc.
Alcon Manufacturing Ltd.
Kyowa Hakko Kogyo Co. Ltd.
Smart & Biggar
LandOfFree
Use of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1949072